CannaPharmaRX Enters Material Definitive Agreement
Ticker: CPMD · Form: 8-K · Filed: Feb 16, 2024 · CIK: 1081938
| Field | Detail |
|---|---|
| Company | Cannapharmarx, Inc. (CPMD) |
| Form Type | 8-K |
| Filed Date | Feb 16, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $2.75 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-action
TL;DR
**CannaPharmaRX just signed a big deal, but the details are still under wraps!**
AI Summary
CannaPharmaRX, Inc. filed an 8-K on February 16, 2024, reporting an event that occurred on February 15, 2024, concerning an "Entry into a Material Definitive Agreement." The filing indicates a significant corporate action, though the specific details of the agreement, such as parties involved or financial terms, are not disclosed in this summary. The company, incorporated in Delaware, has a business address in Calgary, Alberta, Canada.
Why It Matters
This filing signals a potentially significant strategic move for CannaPharmaRX, which could impact its future operations, financial health, and market position.
Risk Assessment
Risk Level: medium — The filing indicates a material agreement but lacks specific details, creating uncertainty about its potential impact.
Key Players & Entities
- CannaPharmaRX, Inc. (company) — Registrant
- February 15, 2024 (date) — Date of earliest event reported
- February 16, 2024 (date) — Filing date
- Delaware (company) — State of incorporation for CannaPharmaRX, Inc.
- Calgary, Alberta, Canada (company) — Business address for CannaPharmaRX, Inc.
FAQ
What was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 15, 2024.
What is the primary item of information disclosed in this 8-K?
The primary item of information disclosed is the "Entry into a Material Definitive Agreement."
When was this 8-K filed with the SEC?
This 8-K was filed with the SEC on February 16, 2024.
What is the state of incorporation for CannaPharmaRX, Inc.?
CannaPharmaRX, Inc. is incorporated in Delaware.
What is the business address provided for CannaPharmaRX, Inc.?
The business address for CannaPharmaRX, Inc. is Suite 3600, 888-3rd Street SW, Calgary, Alberta, Canada.
Filing Stats: 650 words · 3 min read · ~2 pages · Grade level 10.1 · Accepted 2024-02-16 12:02:25
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share CPMD OTC Markets Indicate
- $2.75 — al. The price for each purchase will be $2.75 CDN per gram of product ordered. Cantek
Filing Documents
- canna_8k.htm (8-K) — 32KB
- canna_ex0101.htm (EX-1.1) — 8KB
- 0001683168-24-001042.txt ( ) — 215KB
- cpmd-20240215.xsd (EX-101.SCH) — 3KB
- cpmd-20240215_lab.xml (EX-101.LAB) — 33KB
- cpmd-20240215_pre.xml (EX-101.PRE) — 22KB
- canna_8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. The Supply Agreement is being filed as an exhibit herewith. Exhibit No. Description 1.1 Supply Agreement between CannaPharmaRX, Inc. and D.N.S. Cantek 2019 Ltd dated February 12, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. CANNAPHARMARX, INC. February 16, 2024 B y: /s/ Dean Medwid Name: Title: Dean Medwid CEO 3